Canopy Biosciences, LLC — Form D
Canopy Biosciences, LLC of SAINT LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-31. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-31
- Form: D
- Accession: 0001712948-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $1.1M
- Minimum investment: $20K
- Investors: 15
- Date of first sale: 2016-10-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-291783
Issuer
- Name: Canopy Biosciences, LLC
- CIK: 0001712948
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 4320 FOREST PARK AVENUE, SAINT LOUIS, MO, 63108
- Phone: 314-615-6325
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Crystal Winkeler | Executive Officer | ST. LOUIS, MO |
| David Smoller | Director | St. Louis, MO |
| Edward Weinstein | Director | St. Louis, MO |
| Edward Weinstein | Executive Officer | St. Louis, MO |
| David Kingsley | Director | SOUTH JORDAN, UT |
| Charles Bolten | Director | St. Louis, MO |
Other filings by this issuer (1)
More